The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

Boursier, Jérôme, Mueller, Olaf, Barret, Matthieu, Machado, Mariana, Fizanne, Lionel, Araujo‐Perez, Felix, Guy, Cynthia D., Seed, Patrick C. +6 more·2016·Hepatology
DOI 10.1002/hep.28356

Cited by (1,000)

Items 901–1,000 of 1,000

  1. Endotoxemia and Platelets
    Francesco Violi, Daniele Pastori, Pasquale Pignatelli, Vittoria Cammisotto · 2023 · JACC Basic to Translational Science
  2. Natural Products for the Treatment of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review
    Saverio Nucera, Rosa Maria Bulotta, Stefano Ruga, Rosamaria Caminiti, María del Rosario Serra, Roberto Bava, Fabio Castagna, Carmine Lupia, Mariangela Marrelli, Filomena Conforti et al. · 2023 · Scientia Pharmaceutica
  3. Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice
    Yufang Ding, Karin Yanagi, Fang Yang, Evelyn S. Callaway, Clint Cheng, Martha E. Hensel, Rani Menon, Robert Christopher Alaniz, Kyongbum Lee, Arul Jayaraman · 2024 · eLife
  4. Maternal obesity increases the risk of hepatocellular carcinoma through the transmission of an altered gut microbiome
    Beat Moeckli, Vaihere Delaune, Benoît Thomas P. Gilbert, Andrea Peloso, Graziano Oldani, Sofia El Hajji, Florence Slits, Joana Rodrigues Ribeiro, Ruben Mercier, Adrien Gleyzolle et al. · 2024 · JHEP Reports
  5. Global research trends on gut microbiota and metabolic dysfunction-associated steatohepatitis: Insights from bibliometric and scientometric analysis
    Naqash Alam, Linying Jia, Ao Cheng, Honghao Ren, Yu Fu, Xinhua Ding, Ihtisham Ul Haq, Enqi Liu · 2024 · Frontiers in Pharmacology
  6. Lipoprotein Lipidomics as a Frontier in Non-Alcoholic Fatty Liver Disease Biomarker Discovery
    Luis Vicente Herrera-Marcos, José Miguel Arbonés-Mainar, Jesús Osada · 2024 · International Journal of Molecular Sciences
  7. Diagnostics and omics technologies for the detection and prediction of metabolic dysfunction-associated steatotic liver disease-related malignancies
    Tian Lan, Frank Tacke · 2024 · Metabolism
  8. Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Salim Maher, Jayashi Rajapakse, Emad M. El-Omar, Amany Zekry · 2024 · Seminars in Liver Disease
  9. Nutritional implications in the mechanistic link between the intestinal microbiome, renin-angiotensin system, and the development of obesity and metabolic syndrome
    Victor Hugo Dantas Guimarães, Bárbhara Mota Marinho, Daisy Motta‐Santos, Gabriela da Rocha Lemos Mendes, Sérgio Henrique Sousa Santos · 2022 · The Journal of Nutritional Biochemistry
  10. Interventions for non-alcoholic liver disease: a gut microbial metabolites perspective
    Jin Guo, Chunxia Shi, Qingqi Zhang, Wei Deng, Luyi Zhang, Qian Chen, Danmei Zhang, Zuojiong Gong · 2022 · Therapeutic Advances in Gastroenterology
  11. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis
    Pooja Malhotra, Costica Aloman, Aparna Ankireddy, Hani Khadra, Kohtaro Ooka, Ravinder K. Gill, Seema Saksena, Pradeep Kumar Dudeja, Waddah A. Alrefai · 2017 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  12. Targeting of Secretory Proteins as a Therapeutic Strategy for Treatment of Nonalcoholic Steatohepatitis (NASH)
    Kyeongjin Kim, Kook Hwan Kim · 2020 · International Journal of Molecular Sciences
  13. YQFM Alleviates Side Effects Caused by Dasatinib through the ROCK/MLC Pathway in Mice
    Yuan‐Kai Liu, Yujie Dai, Han Xu, Qianliu Zhou, Fang Li, Boyang Yu, Yuanyuan Zhang, Junping Kou · 2020 · Evidence-based Complementary and Alternative Medicine
  14. A new insight: crosstalk between neutrophil extracellular traps and the gut-liver axis for nonalcoholic fatty liver disease
    Jinping Yin, Yanli Zhu, Rongrong Liu, Weixin Wang, Zhicheng Wang, Jianfeng Wang · 2025 · Frontiers in Immunology
  15. The effects of next generation probiotics on metabolic dysfunction-associated steatotic liver disease: a parallel, double-blind, randomized, placebo-controlled trial
    Sung‐Min Won, Hyunchae Joung, In Gyu Park, Sang Hak Han, Young Lim Ham, Ji-Sook Han, Yoojin Kwon, Dong Joon Kim, Ki Tae Suk · 2025 · Journal of Translational Medicine
  16. Idiosyncratic Drug-Induced Liver Injury: Mechanisms and Susceptibility Factors
    Camilla Stephens, M. Isabel Lucena, Raúl J. Andrade · 2017 · Elsevier eBooks
  17. Urinary microbiome-based metagenomic signature for the noninvasive diagnosis of hepatocellular carcinoma
    Eun Ju Cho, Boram Kim, Su Jong Yu, Suk Kyun Hong, YoungRok Choi, Nam‐Joon Yi, Kwang‐Woong Lee, Kyung‐Suk Suh, Jung‐Hwan Yoon, Taesung Park · 2024 · British Journal of Cancer
  18. Topical rhubarb charcoal-crosslinked chitosan/silk fibroin sponge scaffold for the repair of diabetic ulcers improves hepatic lipid deposition in db/db mice via the AMPK signalling pathway
    Qi Tan, Qifeng He, Ze Peng, Xin Zeng, Yuzhe Liu, Dong Li, Shang Wang, Jianwei Wang · 2024 · Lipids in Health and Disease
  19. Probiotic consumption and hepatic steatosis: results from the NHANES 2011–2016 and Mendelian randomization study
    Yancheng Song, Wencong Guo, Junke Wang, Shuguang Liu, Zhaopeng Li, Yu Li · 2024 · Frontiers in Nutrition
  20. Microbiota and Gut–Liver Axis: An Unbreakable Bond?
    Saraswathy Sivaprasadan, K N Anila, Krishnanunni Nair, Shweta Mallick, Lalitha Biswas, Arun Valsan, Raaj Praseedom, Bipin Kumar G. Nair, S Sudhindran · 2024 · Current Microbiology
  21. Cilostazol Attenuates Hepatic Steatosis and Intestinal Disorders in Nonalcoholic Fatty Liver Disease
    Tianqi Min, Shuting Qiu, Yan Bai, Huan Cao, Jiao Guo, Zheng-Quan Su · 2024 · International Journal of Molecular Sciences
  22. Gut microbes, diet, and genetics as drivers of metabolic liver disease: a narrative review outlining implications for precision medicine
    Jake B. Hermanson, Samar A. Tolba, Evan A. Chrisler, Vanessa Leone · 2024 · The Journal of Nutritional Biochemistry
  23. Metabolites mediate the causal associations between gut microbiota and NAFLD: a Mendelian randomization study
    Chen Ouyang, Pengpeng Liu, Yiwei Liu, Jianwei Lan, Quanyan Liu · 2024 · BMC Gastroenterology
  24. Polysaccharides from Lanzhou Lily Attenuate Nonalcoholic Fatty Liver Disease Modifying the Gut Microbiota and Metabolite Profile
    Zhengdou Li, Xueqi Wang, Xu Li, Xia Chen, Cancan Wang, Ying Mao, Guixiang Teng, Xinliang Zhu, Ji Zhang · 2024 · Chemistry & Biodiversity
  25. Evaluating the therapeutic potential of genetically engineered probiotic Zbiotics (ZB183) for non-alcoholic steatohepatitis (NASH) management via modulation of the cGAS-STING pathway
    Maha Saad, Walaa Ibrahim, Amany Helmy Hasanin, Aya Magdy Elyamany, Marwa Matboli · 2024 · RSC Medicinal Chemistry
  26. Review of the Effects of Antiviral Therapy on Hepatitis B/C-Related Mortality and the Regression of Fibrosis
    Stephen Sinclair, Sean Shearen, Youssef Ghobrial, George Trad, Syed Abdul Basit, David Quan Shih, John K Ryan · 2024 · Viruses
  27. Beyond BMI: revealing metabolic risk in lean MASLD
    Adrian Rotaru, Ermina Stratina, Laura Huiban · 2025 · Archive of Clinical Cases
  28. Underrated enemy – from nonalcoholic fatty liver disease to cancers of the gastrointestinal tract
    Aleksandra Derra, Martyna Bator, Tomasz Menżyk, Michał Kukla · 2018 · Clinical and Experimental Hepatology
  29. Sarcopenia in chronic liver diseases: a translational overview
    Varenka J. Barbero-Becerra, Iván López-Méndez, Alejandra Romo‐Araiza, Víctor Visag-Castillo, Norberto Carlos Chávez-Tapia, Misael Uribe, Eva Juárez-Hernández · 2020 · Expert Review of Gastroenterology & Hepatology
  30. Effects of Hepatitis C Virus Elimination by Direct-Acting Antiviral Agents on the Occurrence of Oral Lichen Planus and Periodontal Pathogen Load: A Preliminary Report
    Yumiko Nagao, Masahide Tsuji · 2021 · International Journal of Dentistry
  31. Circadian Rhythms Coordinated With Gut Microbiota Partially Account for Individual Differences in Hepatitis B-Related Cirrhosis
    Tongyao Wang, Xingyu Rong, Chao Zhao · 2022 · Frontiers in Cellular and Infection Microbiology
  32. A systems biology approach to study non-alcoholic fatty liver (NAFL) in women with obesity
    Abraham Stijn Meijnikman, Dimitra Lappa, Hilde Herrema, Ömrüm Aydin, Kimberly A. Krautkramer, Valentina Tremaroli, Louise E. Olofsson, Annika Lundqvist, Sjoerd C. Bruin, Yaïr I. Z. Acherman et al. · 2022 · iScience
  33. Helicobacter pylori infection increases the risk of nonalcoholic fatty liver disease in diabetic population
    Yi Chen, Ningning You, Chuchen Shen, Juju Wu, Jinshun Zhang · 2023 · Frontiers in Nutrition
  34. Moving beyond descriptions of diversity: clinical and research implications of bacterial imbalance in chronic rhinosinusitis
    Brett Wagner Mackenzie, David W. Waite, Michael Hoggard, Michael W. Taylor, Kristi Biswas, Richard George Douglas · 2017 · Rhinology Journal
  35. A pilot study of microbial signatures of liver disease in those with HIV mono-infection in Rio de Janeiro, Brazil
    Carolyn Yanavich, Hugo Perazzo, Fan Li, Nicole Tobin, David Lee, Sara Zabih, Michelle Morata, Cristiane Almeida, Valdilea Gonçalves Veloso, Beatriz Grinsztejn et al. · 2021 · AIDS
  36. Individuals with Metabolic Syndrome Show Altered Fecal Lipidomic Profiles with No Signs of Intestinal Inflammation or Increased Intestinal Permeability
    Mia J. Coleman, Luis M. Espino, Hernan Lebensohn, Marija V. Zimkute, Negar Yaghooti, Christina L. Ling, Jessica Gross, Natalia Listwan, Sandra Cano, Vanessa Garcia et al. · 2022 · Metabolites
  37. Exploring the interplay between metabolic dysfunction-associated fatty liver disease and gut dysbiosis: Pathophysiology, clinical implications, and emerging therapies
    Said A. Al‐Busafi, Ahmed Alwassief, Ali Madian, Hassan Atalla, Mohamed Aly Abdelkhalek Alboraie, Ashraf Elbahrawy, Mohammed Eslam · 2025 · World Journal of Hepatology
  38. Chlorogenic Acid–Gut Microbiota Interactions: New Insights for Alleviating Chronic Diseases and Health Disorders
    Hui Kong, Juanjuan Han, Xin Meng, Xiaodong Wang, Xin-an Zhang · 2025 · Nutrition Reviews
  39. Magnesium isoglycyrrhizinate attenuates nonalcoholic fatty liver disease by strengthening intestinal mucosal barrier
    Xueying Lai, Hong Zhou, Yu Wan, Jiesi Kuang, Yuhui Yang, Limei Mai, Yumei Chen, Bin Liu · 2024 · International Immunopharmacology
  40. Role of intestinal flora in the development of nonalcoholic fatty liver disease in children
    Jing Zhang, Mengxuan Shi, Chunna Zhao, Guangcai Liang, Chuan Li, Xiaomeng Ge, Caixia Pei, Y Y Kong, Dongdan Li, Wenli Yang et al. · 2024 · Microbiology Spectrum
  41. Intestinal microbiota promoted NiONPs-induced liver fibrosis via effecting serum metabolism
    Jiarong Tang, Hongjun Zhao, Kun Li, Haodong Zhou, Qingyang Chen, Hui Wang, Sheng Li, Jianguang Xu, Yingbiao Sun, Xuhong Chang · 2024 · Ecotoxicology and Environmental Safety
  42. Associations between Serum Mineral Nutrients, Gut Microbiota, and Risk of Neurological, Psychiatric, and Metabolic Diseases: A Comprehensive Mendelian Randomization Study
    Wang Li, Bo‐Min Lv, Yuan Quan, Qiang Zhu, Hongyu Zhang · 2024 · Nutrients
  43. The arginine and nitric oxide metabolic pathway regulate the gut colonization and expansion of Ruminococcous gnavus
    Juan Flores, Jayson M. Antonio, Panan Suntornsaratoon, Vik Meadows, Sheila Bandyopadhyay, Jiangmeng Han, Rajbir Singh, Iyshwarya Balasubramanian, Ravij Upadhyay, Yue Liu et al. · 2024 · Journal of Biological Chemistry
  44. Extraintestinal complications of celiac disease: treatment considerations
    Pilar Lazzano, Elia Fracas, Nicoletta Nandi, Lucia Scaramella, Luca Elli · 2024 · Expert Review of Gastroenterology & Hepatology
  45. Grape pomace extract attenuates high fat diet-induced endotoxemia and liver steatosis in mice
    Victoria Muscia Saez, Diahann J. Perdicaro, Eleonora Cremonini, Valeria Victoria Costantino, Ariel Fontana, Patricia I. Oteiza, Marcela A. Vazquez Prieto · 2025 · Food & Function
  46. Full-length 16S rRNA Sequencing Reveals Gut Microbiome Signatures Predictive of MASLD in children with obesity
    Yu‐Cheng Lin, Chi-Chien Wu, Yun-Er Li, Chun‐Liang Chen, Chia-Ray Lin, Yen‐Hsuan Ni · 2025 · BMC Microbiology
  47. Gut microbiota in the development and progression of chronic liver diseases: Gut microbiota-liver axis
    Aysun Yakut · 2025 · World Journal of Hepatology
  48. Bovine colostrum-derived extracellular vesicles protect against non-alcoholic steatohepatitis by modulating gut microbiota and enhancing gut barrier function
    Daye Mun, Sangdon Ryu, Daniel Junpyo Lee, Min‐Jin Kwak, Hye‐Jin Choi, Anna Kang, Dong-Hyun Lim, Sangnam Oh, Younghoon Kim · 2025 · Current Research in Food Science
  49. Targeting the gut-liver axis with dietary polyphenols to ameliorate metabolic dysfunction-associated steatotic liver disease: advances in molecular mechanisms
    Zuomin Hu, Zeyu He, Yuyan Wang, Zhongxing Chu, Yaping Zhou, Wen Li, Jun Lu, Qinlu Lin, Feijun Luo · 2025 · Critical Reviews in Food Science and Nutrition
  50. Codonopis bulleynana Forest ex Diels (cbFeD) effectively attenuates hepatic fibrosis in CCl4-induced fibrotic mice model
    Xiang Li, Yue Xing, Dechang Mao, Ying Lü, Yunqi Luan, Mei Feng Xu, Hongmin Wang, Chunyan Li, Yanmei Li, Shuangqing Zheng et al. · 2020 · Biomedicine & Pharmacotherapy
  51. Inflammasome-Mediated Cytokines: A Key Connection between Obesity-Associated NASH and Liver Cancer Progression
    Nathalia Soares da Cruz, Gabriel Pasquarelli-do-Nascimento, Augusto Cézar Polveiro e Oliveira, Kelly Grace Magalhães · 2022 · Biomedicines
  52. Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes
    Mohammad Alomari, Mamoon Ur Rashid, Pravallika NA. Chadalavada, Jonathan G. Ragheb, Hammad Zafar, Zoilo Karim Suarez, Shrouq Khazaaleh, Adalberto Jose Gonzalez, Fernando Castro · 2023 · World Journal of Hepatology
  53. Role of intestinal microbiota in the formation of non-alcoholic fatty liver disease
    В. А. Ахмедов, Olga V. Gaus · 2019 · Terapevticheskii arkhiv
  54. Establishment of Novel Mouse Model of Dietary NASH Rapidly Progressing into Liver Cirrhosis and Tumors
    Qianqian Zheng, Masaya Kawaguchi, Hayato Mikami, Pan Diao, Xuguang Zhang, Zhe Zhang, Takero Nakajima, Takanobu Iwadare, Takefumi Kimura, Jun Nakayama et al. · 2023 · Cancers
  55. The role of the gut-liver axis in modulating non-alcoholic fatty liver disease through dietary patterns and microecological agents
    Yucheng Fang, Ziyang Fang, Ziwei Li, Run Yu, Haimeng Zhang, Qinwen Wang, Xiang‐Rong Cheng, Guowei Le, Guoqing Wu · 2023 · Food Bioscience
  56. 17β-Estradiol protects female rats from bilateral oophorectomy-induced nonalcoholic fatty liver disease induced by improving linoleic acid metabolism alteration and gut microbiota disturbance
    Ying Tian, Yuan Xie, Xinyu Hong, Zaixin Guo, Qi Yu · 2024 · Heliyon
  57. Monascus red pigments alleviate high‐fat and high‐sugar diet‐induced NAFLD in mice by modulating the gut microbiota and metabolites
    Wenyan Gao, Xinghao Chen, Shaokang Wu, Jin Lu, Xu Chen, Genxiang Mao, Xiaoqing Wan, Wenmin Xing · 2024 · Food Science & Nutrition
  58. Clinical improvement effect of regulating gut microbiota on metabolic dysfunction-associated steatotic liver disease: Systematic review and meta-analysis of randomized controlled trials
    Juan Wu, Xiaoyang Chen, Jun Qian, Guochun Li · 2024 · Clinics and Research in Hepatology and Gastroenterology
  59. Poly-γ-glutamic acid alleviates slow transit constipation by regulating aquaporin and gut microbes
    Xiaoru Wang, Jie Zhou, Zengkun Sun, Ruilei Jia, Diyi Huang, Dongqi Tang, Tao Xia, Fang Xiao · 2025 · Scientific Reports
  60. Gout drives metabolic dysfunction-associated steatotic liver disease through gut microbiota and inflammatory mediators
    Siyuan Liu, Fan Li, Yunjia Cai, Lin Sun, Linan Ren, Mengsha Yin, Huijuan Cui, Yujie Pan, Xiaokun Gang, Guixia Wang · 2025 · Scientific Reports
  61. Investigating the gut bacteria structure and function of hibernating bats through 16S rRNA high-throughput sequencing and culturomics
    Jian Zhou, Ying Liu, Tao Gu, Jingzhu Zhou, Fengming Chen, Shijun Li · 2025 · mSystems
  62. Effect of Lactobacillus plantarum Extracellular Vesicles on Lipid Metabolism in Mice Fed a High‐Fat Diet
    Shanshan Xu, Chunjing Yu, Mengyao Qin, Yan Zhang, Jiaping Jiang, Wei Liu, Yu Pan, Song Zhang, Xiao‐Yu Zhao · 2025 · Molecular Nutrition & Food Research
  63. Emerging concepts in the diagnosis and management of metabolically associated steatotic liver disease
    Sambit Das, Khushboo Agarwal, Nitin Kapoor, Om Lakhani, Arundhati Das Gupta · 2025 · Current Opinion in Endocrinology Diabetes and Obesity
  64. Liver Fibrosis and Risk of Incident Dementia in the General Population: Systematic Review With Meta‐Analysis
    Mohamad Jamalinia, Fatemeh Zare, Amedeo Lonardo · 2025 · Health Science Reports
  65. The Emerging Challenge of Non-Cirrhotic MASLD-Related Hepatocellular Carcinoma: Etiology, Immunopathology, and Precision Oncology
    Yamin Liu · 2025 · Liver Cancer
  66. Bile salt hydrolase activity as a rational target for MASLD therapy
    Elizabeth V. Jones, Yongtao Wang, Wenchao Wei, James Christopher Reed, Snehal N. Chaudhari, Darrick K. Li, Jérôme Boursier, Sonja Lang, Münevver Demir, Anna Mae Diehl et al. · 2026 · Gut Microbes
  67. Restoring polyamine levels by supplementation of spermidine modulates hepatic immune landscape in murine model of NASH
    Marta Szydlowska, Ginger Lasky, Stephanie N. Oldham, Cristian Rivera, Michael Ford, Bret R. Sellman, Christopher J. Rhodes, Taylor S. Cohen · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  68. Effects of isolation and confinement on gastrointestinal microbiota–a systematic review
    Bea Klos, Christina Steinbach, Jasmin Ketel, Claude Lambert, John Penders, Joel M. Dore, Paul Enck, Isabelle Mack · 2023 · Frontiers in Nutrition
  69. Correlation of non-alcoholic fatty liver disease and gut microflora: clinical reports and treatment options
    Pranali Anandrao Jadhav, Asha Byju Thomas, Rabindra Kumar Nanda, Sohan S. Chitlange · 2024 · Egyptian Liver Journal
  70. Navigating the Link Between Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis and Cardiometabolic Syndrome
    Sheila Gato, Vanessa García‐Fernández, Antonio Gil‐Gómez, Ángela Rojas, Rocío Montero‐Vallejo, Rocío Múñoz‐Hernández, Manuel Romero‐Gómez · 2024 · European Cardiology Review
  71. Serum levels of immunoglobulins in an adult population and their relationship with nonalcoholic fatty liver disease
    Shao-Mei Sun, Yan-Yan Wang, Qing Zhang, Li Liu, G. Meng, Z. Yao, Hong-Mei Wu, Yang Xia, X. Bao, Ye-Qing Gu et al. · 2018 · Journal of Digestive Diseases
  72. Non-alcoholic Steatohepatitis: Comparison of Intestinal Microbiota between Different Metabolic Profiles. A Pilot Study
    Juliano Machado de Oliveira, Fábio Lima Pace, Fabiana de Faria Ghetti, Kátia Valéria Bastos Dias Barbosa, Dionéia Evangelista Cesar, Júlio Maria Fonseca Chebli, Lincoln Eduardo Villela Vieira de Castro Ferreira · 2020 · Journal of Gastrointestinal and Liver Diseases
  73. The metabolic effect of fructose on normal rats in a mild dose with glucose and saccharose as control
    Ge Song, Wentao Qi, Yong Wang, Shaojie Pang, Yong Li · 2021 · Food & Nutrition Research
  74. Green Plant Pigment, Chlorophyllin, Ameliorates Non-alcoholic Fatty Liver Diseases (NAFLDs) Through Modulating Gut Microbiome in Mice
    You Yang, Xile Jiang, Stephen Jacob Pandol, Yuan‐Ping Han, Xiaofeng Zheng · 2021 · Frontiers in Physiology
  75. Alleviation of Hepatic Steatosis: Dithizone-Related Gut Microbiome Restoration During Paneth Cell Dysfunction
    Saisai Zhang, Hein Min Tun, Dengwei Zhang, Hau-Tak Chau, Fung‐Yu Huang, Hin Fai Kwok, Danny K.-H. Wong, Lung‐Yi Mak, Man‐Fung Yuen, Wai‐Kay Seto · 2022 · Frontiers in Microbiology
  76. Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis
    Valentina Liakina, Sandra Strainienė, Ieva Stundienė, Vaidota Maksimaityte, Edita Kazėnaitė · 2022 · World Journal of Hepatology
  77. Prebiotics Supplementation Ameliorates High Fat High Sugar Diet-Associated Oxidative Stress
    Haroon Rashid · 2020 · Pakistan Veterinary Journal
  78. Nonalcoholic steatohepatitis and the intestinal microbiota
    David B Haslam · 2016 · Hepatology
  79. Probiotics and synbiotics targeting the intestinal microbiome attenuate non-alcoholic fatty liver disease
    Luis Vitetta, Jeremy David Henson · 2020 · HepatoBiliary Surgery and Nutrition
  80. Clearing Steatosis Prior to Liver Surgery for Colorectal Metastasis: A Narrative Review and Case Illustration
    Andrea Peloso, Matthieu Tihy, Beat Moeckli, Laura Rubbia‐Brandt, Christian Toso · 2022 · Nutrients
  81. Multidimensional landscape of non‐alcoholic fatty liver disease‐related disease spectrum uncovered by big omics data: Profiling evidence and new perspectives
    Zhengyi Zhu, Yuyan Chen, Xueqian Qin, Shujun Liu, Jinglin Wang, Haozhen Ren · 2023 · Smart Medicine
  82. The influence of liver transplantation on the interplay between gut microbiome and bile acid homeostasis in children with biliary atresia
    Birgit J. Waldner, Denise Aldrian, Thomas Zöggeler, Herbert Oberacher, Rupert Oberhuber, Stefan Schneeberger, Franka Messner, Anna-Maria Schneider, Benno Kohlmaier, Roland Lanzersdorfer et al. · 2023 · Hepatology Communications
  83. Benefits of Combining Sonchus brachyotus DC. Extracts and Synbiotics in Alleviating Non-Alcoholic Fatty Liver Disease
    Wen-wu Huang, Boyuan Shen, Xiumei Li, Tongcun Zhang, Xiang Qin Zhou · 2023 · Foods
  84. Nonalcoholic Fatty Liver Disease: Changes in Gut Microbiota and Blood Lipids
    Keen Yang, Jieying Zeng, Huaiyu Wu, Huiyu Liu, Zhimin Ding, Weiyu Liang, Linghu Wu, Ziwei Lin, Wenhui Huang, Jinfeng Xu et al. · 2024 · Journal of Clinical and Translational Hepatology
  85. Integrated serum metabolomics, 16S rRNA sequencing and bile acid profiling to reveal the potential mechanism of gentiopicroside against nonalcoholic steatohepatitis in lean mice
    Zeyun Li, Xueya Zhu, Chenhao Li, Ruiting Tang, Yuanyuan Zou, Shuaibing Liu · 2024 · Journal of Ethnopharmacology
  86. Gut microbiome in non-alcoholic fatty liver disease
    Anastasios Mpountouridis, Christina Tsigalou, Ioanna Bezirtzoglou, Eugenia Bezirtzoglou, Elisavet Stavropoulou · 2025 · Frontiers in Gastroenterology
  87. Gut microbiota differences, metabolite changes, and disease intervention during metabolic - dysfunction - related fatty liver progression
    Jianzhong Shu, Yu-Han Huang, Xiaohong He, Fengying Liu, Qian-Qian Liang, Xue-Tong Yong, Yongfang Xie · 2025 · World Journal of Hepatology
  88. Microbial translocation and gut damage is associated with hepatic fibrosis but not steatosis in women with and without HIV
    Maria Duarte, Phyllis C. Tien, Ani A. Kardashian, Yifei Ma, Peter W. Hunt, Mark H. Kuniholm, Michelle Floris-Moore, Margaret A. Fischl, Audrey L. French, Elizabeth T. Topper et al. · 2025 · AIDS
  89. Regulating Effects of Three Polysaccharides on Gut Microbiota in Felines and Canines: Insights from In Vitro Digestion, Fecal Fermentation, and Lactic Acid Bacterial Fermentation
    Huasong Bai, Tong Liu, Hengyan Wang, Yunliang Li, Zhanzhong Wang · 2025 · Journal of Agricultural and Food Chemistry
  90. Gut microbiota mediates SREBP-1c-driven hepatic lipogenesis and steatosis in response to zero-fat high-sucrose diet
    Mattias Bergentall, Valentina Tremaroli, Chuqing Sun, Marcus Henricsson, Muhammad Tanweer Khan, Louise Mannerås Holm, Lisa M. Olsson, Per‐Olof Bergh, Antonio Molinaro, Adil Mardinoğlu et al. · 2025 · Molecular Metabolism
  91. The alleviating effect of Scutellaria amoena extract on the regulation of gut microbiota and its metabolites in NASH rats by inhibiting the NLRP3/ASC/caspase-1 axis
    Yuping Lin, Qionglian Fang, Sheng-Nan Fu, Xinping Li, Rui Shi, Chenghong Du, Xue Qiao, Xunqing Yin, Yong-Cheng Zeng, Xiujuan Zhao et al. · 2023 · Frontiers in Pharmacology
  92. Pilot Study: Safety and Performance Validation of an Ingestible Medical Device for Collecting Small Intestinal Liquid in Healthy Volunteers
    Alexandre Tronel, Anne‐Sophie Silvent, Elena Buelow, Joris Giai, Corentin Leroy, Marion Proust, Donald K. Martin, Audrey Le Gouëllec, Thomas Soranzo, Nicolas Mathieu · 2024 · Methods and Protocols
  93. Fufang Zhenzhu Tiaozhi polysaccharides ameliorates high-fat diet-induced non-alcoholic steatohepatitis and intestinal flora disorders in mice
    Tian Lan, Jiali Wu, Bulang Tang, Xu He, Xin Ding, Xiaoling Ren, Yanfang Fu, Qin Yuan, Wen Liu, Shengpeng Wang et al. · 2024 · Journal of Functional Foods
  94. Etiology-Dependent Microbiome Differences in Hepatocellular Carcinoma Development
    Nevena Todorović, Serena Martinelli, Giulia Nannini, Ralf Weiskirchen, Amedeo Amedei · 2024 · International Journal of Molecular Sciences
  95. Opisthorchis viverrini infection induces metabolic disturbances in hamsters fed with high fat/high fructose diets: Implications for liver and kidney pathologies
    Ornuma Haonon, Zhigang Liu, Rungtiwa Dangtakot, Porntip Pinlaor, Anucha Puapairoj, Ubon Cha’on, Kitti Intuyod, Thatsanapong Pongking, Chanakan Jantawong, Chatchawan Sengthong et al. · 2022 · The Journal of Nutritional Biochemistry
  96. Intestinal microbiota in the treatment of metabolically associated fatty liver disease
    Ji-Shuai Wang, Jinchun Liu · 2022 · World Journal of Clinical Cases
  97. Gut ecological networks reveal associations between bacteria, exercise, and clinical profile in non-alcoholic fatty liver disease patients
    Susanne Csader, Xiuqiang Chen, Howell Leung, Ville Männistö, Heikki Pentikäinen, Milla‐Maria Tauriainen, Kai P. Savonen, Hani S El-Nezami, Ursula Schwab, Gianni Panagiotou · 2023 · mSystems
  98. Dysregulation of Gut Microbiota‐Derived Neuromodulatory Amino Acid Metabolism in Human Immunodeficiency Virus ‐Associated Neurocognitive Disorder: An Integrative Metagenomic and Metabolomic Analysis
    Xue Chen, Jiaqi Wei, Zhen Li, Yang Zhang, Xin Zhang, Ling Zhang, Xia Wang, Yulin Zhang, Tong Zhang · 2024 · Annals of Neurology
  99. Racial and Ethnic Disparities in NAFLD: Harnessing Epigenetic and Gut Microbiota Pathways for Targeted Therapeutic Approaches
    Mohamed Zaiou, Olivier Joubert · 2025 · Biomolecules
  100. Targeting the gut microbiota and lipid metabolism: potential mechanisms of natural products for the treatment of non-alcoholic fatty liver disease
    Yutian Zhang, Tianlin Wang, Junquan Han, Jielin Song, Chaoshuai Yang, Lei Liang, Huizhen Li, Hong Wang · 2025 · Frontiers in Pharmacology